Aaron Royston insider trades: Elevation Oncology (ELEV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Aaron reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 25, 2022 | ELEV | ↓ Sell | 702,737 | $4.12 | $2.9M | Direct | May 27, 2022 (2d) |
| Oct 25, 2021 | VTYX | ↑ Buy | 312,500 | $16.00 | $5.0M | Indirect | Oct 25, 2021 (0d) |
| Jun 29, 2021 | ELEV | ↑ Buy | 625,000 | $16.00 | $10.0M | Direct | Jul 1, 2021 (2d) |
| Jun 24, 2019 | AKRO | ↑ Buy | 250,000 | $16.00 | $4.0M | Indirect | Jun 25, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Aaron Royston's insider trades
Aaron Royston is an insider at Elevation Oncology (ELEV). Since Jun 24, 2019, Aaron has reported 3 open-market purchases worth $19.0M and 1 sale worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELEV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.